SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-01-511048
Filing Date
2001-04-27
Accepted
2001-04-27 00:00:00
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BIOTECHNOLOGY VALUE FUND L PBVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G a2046825zsc13g.txt SC 13G 21553
2 EXHIBIT 1 a2046825zex-1.txt EX-1 2677
  Complete submission text file 0000912057-01-511048.txt   26567
Mailing Address 2408 TIMBERLOCH PLACE B-4 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-4 WOODLANDS TX 77380 2813675892
ZONAGEN INC (Subject) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-52909 | Film No.: 1614231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice